Wonbiogen Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Wonbiogen has a total shareholder equity of ₩34.6B and total debt of ₩6.2B, which brings its debt-to-equity ratio to 18.1%. Its total assets and total liabilities are ₩44.3B and ₩9.7B respectively. Wonbiogen's EBIT is ₩6.4B making its interest coverage ratio -38.6. It has cash and short-term investments of ₩12.5B.
Anahtar bilgiler
18.1%
Borç/özkaynak oranı
₩6.24b
Borç
| Faiz karşılama oranı | -38.6x |
| Nakit | ₩12.54b |
| Eşitlik | ₩34.58b |
| Toplam yükümlülükler | ₩9.68b |
| Toplam varlıklar | ₩44.26b |
Son finansal sağlık güncellemeleri
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: A307280's short term assets (₩24.2B) exceed its short term liabilities (₩8.9B).
Uzun Vadeli Yükümlülükler: A307280's short term assets (₩24.2B) exceed its long term liabilities (₩821.3M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: A307280 has more cash than its total debt.
Borcun Azaltılması: Insufficient data to determine if A307280's debt to equity ratio has reduced over the past 5 years.
Borç Kapsamı: A307280's debt is well covered by operating cash flow (97%).
Faiz Kapsamı: A307280 earns more interest than it pays, so coverage of interest payments is not a concern.